Vivos Inc (OTC:RDGL)
| Market Cap | 21.63M-48.5% |
| Revenue (ttm) | 99.10K+91.5% |
| Net Income | -3.60M-8.2% |
| EPS | -0.01-1.3% |
| Shares Out | 493.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 214,709 |
| Open | 0.04 |
| Previous Close | 0.04 |
| Day's Range | 0.04 - 0.05 |
| 52-Week Range | 0.04 - 0.12 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About RDGL
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$RDGL stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in RDGL holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by RDGL's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
RDGL Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New RDGL patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to RDGL from public contracts
Source: USAspending.gov
RDGL Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from RDGL’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score